We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AUSTIN, Texas, Nov. 8 /PRNewswire-FirstCall/ -- Encore Medical Corporation announced today that it has acquired Cefar AB, a leading European provider of electrotherapy and rehabilitation...
AUSTIN, Texas, Nov. 3 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") today announced that it had completed its going private transaction through a merger with a...
AUSTIN, Texas, Nov. 2 /PRNewswire-FirstCall/ -- Encore Medical Corporation ("Encore") (NASDAQ:ENMC) today announced that at a special meeting of its stockholders, its stockholders voted to adopt...
AUSTIN, Texas, Oct. 27 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") announced today the determination of the pricing for its previously announced tender offer to...
AUSTIN, Texas, Oct. 26 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") today announced its financial results for its third quarter ended September 30, 2006...
AUSTIN, Texas, Oct. 17 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) today announced preliminary unaudited financial results from continuing operations for its third quarter...
AUSTIN, Texas, Oct. 13 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") announced today that it had commenced a cash tender offer to purchase any and all of the...
AUSTIN, Texas, Oct. 12 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) announced today that the Company will release third quarter 2006 financial results prior to the opening...
AUSTIN, Texas, Sept. 25 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") announced today that, effective October 1, 2006, Peter W. Baird will join Encore as Group...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions